Dr. Falk Lohoff serves as the Chief of the Section on Clinical Genomics and Experimental Therapeutics (CGET). He received his medical degree from Humboldt University of Berlin in 2002, and completed residency training in psychiatry and a fellowship in neuropsychopharmacology at the University of Pennsylvania. He is board certified in Psychiatry and Addiction Medicine. He was Assistant Professor of Psychiatry at the University of Pennsylvania from 2007-2014, after which he joined the NIH intramural program as a Lasker Clinical Research Scholar. Dr. Lohoff has worked on clinical trials in addictions, mood and anxiety disorders and has also been involved in direct patient care as the attending at the University of Pennsylvania and now as senior attending clinician at the NIH. His research is focused on translational medicine and spans areas of molecular genetics, epigenetics, imaging-genetics, pharmacogenetics and clinical experimental trials.